
According to data from Benzinga Pro, during Q4, Cormedix's (NASDAQ:CRMD) reported sales totaled $56.40 thousand. Despite a 9.08% increase in earnings, the company posted a loss of $7.79 million. Cormedix collected $38.09 thousand in revenue during Q3, but reported earnings showed a $8.57 million loss.